| CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY |
CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY The condensed financial statements of Blue Foundry Bancorp (parent company only) are presented below: | | | | | | | | | | | | | | | | Condensed Balance Sheets | | | | | | | December 31, 2025 | | December 31, 2024 | | (In thousands) | | Assets: | | | | | Cash and cash equivalents | | $ | 23,304 | | | $ | 41,297 | | | Investment in banking subsidiary | | 269,659 | | | 270,904 | | | ESOP loan receivable | | 19,256 | | | 19,932 | | | Other investments | | 520 | | | 226 | | | Other assets | | 284 | | | 446 | | | Total Assets | | $ | 313,023 | | | $ | 332,805 | | | Liabilities and Stockholders’ Equity: | | | | | | Total liabilities | | $ | 282 | | | $ | 607 | | | Total stockholders’ equity | | 312,741 | | | 332,198 | | | Total Liabilities and Stockholders’ Equity | | $ | 313,023 | | | $ | 332,805 | |
| | | | | | | | | | | | | | | | Condensed Statements of Comprehensive Loss | | | | | | | Year Ended December 31, | | | 2025 | | 2024 | | (In thousands) | | Income: | | | | | | Interest on ESOP loan receivable | | $ | 648 | | | $ | 669 | | | | | | | | Total income | | 648 | | | 669 | | | Expenses: | | | | | | | | | | | | | | | | Other expenses | | 4,511 | | | 3,411 | | | Total expenses | | 4,511 | | | 3,411 | | | Loss before income tax benefit | | (3,863) | | | (2,742) | | | Income tax benefit | | — | | | — | | | Loss before undistributed earnings of subsidiary | | (3,863) | | | (2,742) | | | Equity in undistributed earnings of banking subsidiary | | (6,162) | | | (9,169) | | | Net loss | | $ | (10,025) | | | $ | (11,911) | | | | | | | | Comprehensive loss: | | | | | | Net loss | $ | $ | (10,025) | | | $ | (11,911) | | | Other comprehensive income | | 2,883 | | | 3,926 | | | Comprehensive loss | $ | $ | (7,142) | | | $ | (7,985) | |
| | | | | | | | | | | | | | | | Condensed Statements of Cash Flows | | | | | | Year Ended December 31, | | | 2025 | | 2024 | | (In thousands) | | Cash flows from operating activities: | | | | | | Net loss | $ | $ | (10,025) | | | $ | (11,911) | | | Adjustments to reconcile net loss to net cash provided by operating activities: | | | | | | Equity in undistributed earnings of subsidiary | | 6,162 | | | 9,169 | | | | | | | | | | | | | ESOP and stock-based compensation expense | | 1,291 | | | 1,327 | | | Decrease in other assets | | 93 | | | 63 | | | Decrease in other liabilities | | (383) | | | (290) | | | Net cash used by operating activities | | (2,862) | | | (1,642) | | | | | | | | Cash flows from investing activities: | | | | | | | | | | | Purchase of other investments | | (225) | | | (150) | | | | | | | | Repayment of ESOP loan | | 676 | | | 656 | | | Net cash provided by investing activities | | 451 | | | 506 | | | | | | | | Cash flows from financing activities: | | | | | | Issuance of common stock | | 667 | | | 498 | | | Purchase of treasury stock | | (16,270) | | | (19,423) | | | Proceeds from exercised options | | 21 | | | — | | | Net cash used in financing activities | | (15,582) | | | (18,925) | | | Net decrease in cash and cash equivalents | | (17,993) | | | (20,061) | | | Cash and cash equivalents at beginning of year | | 41,297 | | | 61,358 | | | Cash and cash equivalents at end of year | $ | $ | 23,304 | | | $ | 41,297 | |
|